SS
LFCR icon

Sunbelt Securities’s Lifecore Biomedical LFCR Stock Holding History

Sunbelt Securities’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60 Sell
16
-4
-20% -$28 ﹤0.01% 2746
2025
Q4 		$164 Sell
20
-4
-17% -$30 ﹤0.01% 2467
2025
Q3 		$177 Buy
+24
New +$182 ﹤0.01% 2430

Other funds holding LFCR

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GC
Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sunbelt Securities's LFCR Position: Q1 2026 in Review

Sunbelt Securities reduced its Lifecore Biomedical (LFCR) stake by 20% in Q1 2026, selling an estimated $28 and leaving 16 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

Sunbelt Securities first reported a position in LFCR in Q3 2025 and has held it in 3 quarters since. The position peaked at $177 in Q3 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Sunbelt Securities held 16 shares of Lifecore Biomedical worth $60 as of Q1 2026.
  • Sunbelt Securities sold 4 Lifecore Biomedical shares in Q1 2026, an estimated $28.
  • Lifecore Biomedical made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2746 holding.
  • Sunbelt Securities first reported a position in Lifecore Biomedical in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Lifecore Biomedical position peaked at $177 in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.